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IntroductIon
More than 20,000 kinds of plants are used in traditional 
medicines worldwide. Traditional Chinese medicine (TCM) is 
famous	for	its	unique	curative	effects.	Xanthii Fructus (XF), 
or “cangerzi” in Chinese, is widely studied as a traditional 
Chinese medicinal agent. XF is the dried fruit of the composite 
plant Xanthium sibiricum Patr. With involucre as shown in 
Figure 1. The fruit ripens in autumn, is harvested and dried, 
and the impurities such as stems and leaves are removed. 
XF	was	 first	 described	 in	 Shennong’s	Classic of Materia 
Medica (during the Qin and Han Dynasties) and was later 
recorded in the Compendium of Materia Medica (Ming 
Dynasty). XF is often used to treat rhinitis, headache due 
to a cold, limb cramps and numbness, ulcers, and itching.[1] 
Modern pharmacological research has shown that XF also 
exerts	 hypoglycemic,	 anti‑inflammatory,	 and	 other	 effects.
[2-4]	Although	XF	 has	 high	 efficacy,	 its	 toxicity	 cannot	 be	
ignored. Cases of poisoning induced by accidental ingestion 
of XF are often reported, mainly resulting from drug-induced 
liver	injury.[5] This toxicity limits the clinical use of XF. To 
reduce	the	toxicity	of	XF	and	improve	its	therapeutic	effects,	
processed, especially stir-fried, products are often used in 
China.
In recent years, there have been many reports on XF. The 
main chemical constituents of XF are sesquiterpenoid lactone, 
glycoside,	 and	 phenolic	 acid;	 it	 also	 contains	 unsaturated	
fatty acids and other substances.[6-11] In the 2015 edition of 
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Pharmacopoeia of the People’s Republic of China (ChP), 
carboxyl atractyloside was used as an index to evaluate the 
toxicity of XF, while chlorogenic acid content was used to 
evaluate	 quality.	 Some	methods,	 such	 as	 high‑performance	
liquid chromatography (HPLC) and gas chromatography-mass 
spectrometry	(GC‑MS),	can	provide	a	reference	for	optimizing	
quality and safety controls of XF.[12,13]
This article systematically reviews recent studies on the 
phytochemistry, pharmacology, and toxicology of XF. The 
purpose was to study XF in depth in order to elucidate its 
application and pharmacological activity and to discuss the 
limitations of current studies. Future research directions for 
XF	are	considered	in	order	to	provide	a	scientific	basis	for	the	
development of new drugs and to elucidate its full therapeutic 
potential.
phytocheMIstry
XF contains an abundance of chemical constituents. 
Increasing research activity has enhanced our understanding 
of its chemical constituents. Thus far, chemical constituents 
including phenolic acid, sesquiterpenes, glycosides, thiazine, 
and lignans have been discovered
Phenylpropanoids
Phenylpropanoids are important chemical components in XF, 
and phenolic acids are the most common phenylpropanoids. 
There are many phenolic acid compounds, and chlorogenic 
acid is the most abundant organic acid in XF. Phenolic acid 
plays	 an	 important	 role	 in	 the	 clinical	 effects	 of	XF.	 It	 has	
favorable antioxidant, anti-inflammatory, antimicrobial, 
enzyme inhibitory, liver cell protective, and platelet aggregation 
inhibitory activities, as well as other biological activities.
[14-20] In addition to chlorogenic acid, other phenolic acids 
exist in XF, such as neochlorogenic acid, cryptochlorogenic 
acid,	caffeic	acid	(1),	ferulic	acid	(2),	isochlorogenic	acid	(3),	
protocatechuic	acid	 (4),	and	caffeoylquinic	acids.[21-25] Other 
studies have shown that the phenolic acid content in these 
medicinal materials is related to factors such as origin, harvest 
time, processing time, and temperature.[22] The names and 
chemical structures of other phenylpropanoids are shown in 
Table 1 and Figure 2.
Glycoside
Glycosides are widely distributed in the roots, stems, leaves, 
flowers, and fruits of plants.[40] They are mostly colored 
crystals that dissolve in water.[41] They are generally bitter 
and	some	are	highly	toxic.	Sugars	and	other	substances	are	
formed by hydrolysis.[41] The toxic components of XF are 
mainly water-soluble glycosides.[34] Jiang (2017) isolated 
and	 identified	 the	 toxic	 parts	 based	 on	 their	 selection	 by	
pharmacological screening. Experiments have shown that 
the toxic components of XF are carboxyatractyloside (1), 
atractyloside (2), and 3’,4’-dedisulfated-atractyloside (3).[35-37] 
After stir-frying, the content of atractyloside decreases, 
and the toxicity of XF decreases.[36] The glycosides in XF 
include hemiterpene glycosides, monoterpene glycosides, and 
diterpenoid glycosides. Details of the glycoside compounds 
are shown in Table 2. The corresponding chemical structures 
are shown in Figure 3.
Sesquiterpenoid
The characteristic components of Compositae are 
sesquiterpenoid lactones.[45,46] More than 300 sesquiterpenoid 
lactones have been isolated from Compositae alone. These 
compounds	 have	 anti‑inflammatory,	 analgesia,	 antitumor,	
anti-allergic, antibacterial, antiulcer, and other activities, and 
they	 affect	 the	 central	 nervous	 system	 and	 cardiovascular	
system.[47-54] Most of the sesquiterpene lactones in XF have 
been extracted with petroleum ether, methanol, ethanol, 
chloroform, acetone, and other organic solvents. These 
organic solvents have been further extracted, removed, and 
extracted by column chromatography to obtain sesquiterpene 
lactones.[55] To date, approximately forty sesquiterpene 
lactones	have	been	identified	in	XF	[Table 3]. The detailed 





D (2), fructusol A (3), (-)-1-O-β-D-glucopyranosyl-2-{2-met
hoxy-4-[1-(E)-propen-3-ol] phenoxyl}-propane-3-ol (4), and 
dihydrode‑hydrodiconiferyl	alcohol	(5);	the	other	components	
are shown in Table 4.	Among	them,	in	2017,	xanthiumnolic	B	
was	shown	to	have	anti‑inflammatory	effects.[66]
Thiazides
Te n  t h i a z i d e  c o m p o u n d s  h a v e  b e e n  r e p o r t e d 
to	 date:	 xanthiazone	 (1),	 2‑hydroxy‑xanthiazone	 (2),	
7-hydroxymethyl-8,8-dimethy l-4,8-dihydrobenzol 
- [1,4]-thiazine-3,5-dione-11-O-β-D-glucopyranosi
de (3), 2-hydroxy-7-hydroxymethyl-8,8-dimethyl-4,8 
-dihydrobenzol[1,4]thiazine-3,5-dione-11-O-β-D-glucopyra
noside (4), 7-hydroxymethyl-8,8-dimethyl-4,8-dihydrobenzol 
‑[1,4]‑thiazine‑3,5‑dione‑(2‑O‑caffeoyl)‑β-D-glucopyranosi
de (5), xanthialdehyde (6), chrysophanic acid (7), emodin (8), 
aloe emodin (9), and 7-[(β‑D‑apiofuranosyl‑(1→6)‑β-D-gluc
opyranosyl) oxymethy]-8,8-dimethyl-4,8-dihydrobenzo[1,4]
thiazine-3,5-dione (10). The detailed chemical structures are 
shown in Table 5 and Figure 6.
Others
Ahuja	and	Nigam	reported	that	XF	contains	anthraquinones.	
In	 addition,	flavonoids,	 alkaloids,	 heterocyclic	 compounds,	
adenosine, sterols, fatty acids, coumarins, and other compounds 
have	been	identified	in	XF.[31,71,72]
analytIcal Methods
Presently, in ChP, the quality of XF is controlled by HPLC 
and	the	content	of	chlorogenic	acid	is	at	least	0.25%.	Among	
the abovementioned analytical methods, HPLC is the most 
frequently used, and is the main method used for the analysis 
of other compounds.[12] Although HPLC is a simple and 
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accurate method, it does not provide a comprehensive method 
for the quality control of drugs. Detection of chlorogenic 
acid content only when determining the content of XF is 
also a disadvantage because the content of other chemical 
components in XF has not been determined, which is not 
favorable for quality control.
Recently, with the development of analytical instruments, 
there have been many reports on the quality control 
methods for XF. For phenolic acids and glycosides, 
commonly used analytical methods include HPLC, 
h i g h - p e r f o r m a n c e  c a p i l l a r y  e l e c t r o p h o r e s i s , 
ultra‑performance	 liquid	 chromatography	 (UPLC),	
ultra-HPLC-triple quadrupole-linear ion trap mass 
s p e c t r om e t r y 	 ( U PLC ‑QTRAP ‑MS /MS ) , 	 a n d	
HPLC-photodiode array.  For anthraquinones and 
flavonoids	 in	XF,	UPLC‑QTRAP‑MS/MS	 is	 an	 effective	
method for the simultaneous determination of these 
two compounds.[73,74] Volatile oils can be detected by 
HPLC‑evaporative	 light‑scattering	 detector	 and	GC‑MS.	
Other methods, such as liquid chromatography-diode 
array spectrometry/electrospray ionizat ion mass 
spectrometry	 (HPLC‑DAD/ESI‑MS)	 and	UPLC	 coupled	
with	time‑of‑fight	mass	spectrometry	(UPLC/Q‑TOF‑MS),	
have also been used to determine the chemical content of 
Table 1: Phenylpropenoids reported from Xanthii Fructus




















Chlorogenic acid Fruits [28]
Coniferine Fruits [35]
Erythro-guaiacylglycerol-8-O-4’-(coniferyl alcohol) ether Fruits [36]
Erythro‑guaiacylglycerol‑β‑coniferyl	aldehyde	ether Fruits [26]
Ferulic acid Fruits [26]
Icariside D1 Fruits [37]
Icariside F2 Fruits [32]





Protocatechuic acid Fruits [24]
rel‑(2α,3β)‑7‑O‑methylcedrusin Fruits [40]
Threo-1-phenyl-(4-hydroxy-3-methoxy)-2-phenyl-(4”-hydroxy-3”-methoxy)-1,3-propanediol Fruits [38]
Threo-guaiacylglycerol-8-O-4’- (coniferyl alcohol) ether Fruits [26]
Threo‑guaiacylglycerol‑β‑coniferyl	aldehyde	ether Fruits [26]
Xanthiumnolic A Fruits [39]
Xanthiumnolic C Fruits [39]
Xanthiumnolic D Fruits [39]
Xanthiumnolic E Fruits [39]
ω‑hydroxypropioguaiacone Fruits [32]
[Downloaded free from http://www.wjtcm.net on Monday, March 15, 2021, IP: 10.232.74.26]
Jiang, et al. A review of Xanthii Fructus
World J Tradit Chin Med | Volume 6 | Issue 4 | October-December 2020 411
XF.[40,68] Furthermore, these methods can detect changes 
in the active and toxic components of XF with sensitivity 
before and after processing. In recent years, researchers 
have studied the relationship between pharmacological 
activity and the content of chemical constituents in plants. 
This analytical method may bring about a great change in 
the quality control of XF.
pharMacologIcal actIvItIes and clInIcal 
applIcatIon
Pharmacological activities
The earliest application of Xanthium in China can be traced 
back	 to	 the	Qin	dynasty.	The	 roots,	 stems,	 leaves,	flowers,	




on many microorganisms, such as Staphylococcus aureus, 
Pneumococcus, and Group b Streptococcus.[75,76] It has 
demonstrated	clear	bacteriostatic	effects	on	Escherichia coli 
and Bacillus subtilis,	whereby	 the	 bacteriostatic	 effect	 on 
E. coli is greater than that on B. subtilis.[77]
Acetone and ethanol extracts of XF have also demonstrated 
inhibitory	effects	on	Trichoderma rubra. Chloroform extract 
and n-butanol extract of XF can inhibit Demodex oculi, and 
mucous toxicity tests found no irritation.[78] The inhibition rate 
of	hepatitis	B	virus	(HBV)	DNA	by	XF	polysaccharides	was	
25%–50%.[63] XF extracts can control the pathological changes 
caused	by	HBV	without	affecting	transaminase	levels.[79] In 
addition, an ethanol extract of XF can completely inhibit the 
growth	of	herpes	virus	at	0.1	mg/mL,	and	has	no	toxic	effect	
on normal cells.[80]
Anti‑inflammatory and analgesic activities
Intraperitoneal	injection	of	methanol	extract	of	XF	at	250	mg/kg	
increased	analgesia	by	30%–60%.	XF	has	some	anti‑inflammatory	




gene is a potent inhibitor of nitric oxide, prostaglandin E2, and 






Among	 the	 various	 extracts	 of	XF,	 a	 70%	alcohol	 extract	
was found to have the best anti-allergic effect, and its 
anti-allergy mechanism may be related to the inhibition of 
Ca2+	influx	in	mast	cells	and	the	intracellular	cyclic	adenosine	
monophosphate (cAMP) content.[83-85] Dai et al. (in 2008) 
showed that xanthium can inhibit allergic reactions rapidly. 
Accordingly,	70%	alcohol	extracts	of	XF	inhibit	anaphylactic	
shock in mice, passive skin reactions in rats in vivo, and reduce 
histamine and beta-aminohexase release by rat mast cells 
in vitro.	It	was	found	to	have	no	significant	effect	on	the	skin	
Table 2: Glycosides reported from Xanthii Fructus
Compound name Part of plant Reference
Hemiterpene glycoside
2‑methyl‑3‑buten‑2‑ol‑β‑D‑apiofuranosyl‑(1→6)‑β‑D‑glucopyranoside Fruits [42]











Fructusnoid A Fruits [44]
Fructusnoid	B Fruits [44]
Fructusnoid C Fruits [44]
Figure 1: The plant Xanthium sibiricum Patr. and Xanthii Fructus
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response to histamine or serotonin in rats. These results showed 
that XF can stabilize hypertrophic cell membranes, reduce the 




Extracts of XF have been shown to scavenge superoxide 
radicals	 and	hydroxyl	 radicals;	 they	have	 also	been	 shown	
to delay and reduce lipid peroxidation.[54] In addition, XF 
extracts can reduce the lipid peroxide content in tissues and 
increase the activity of superoxide dismutase. The antioxidant 
activity of an XF extract was better at scavenging superoxide 
free radicals, while that of an alcohol extract was better at 
scavenging hydroxyl free radicals.[86]
Antitumor effect
Using	 a	 serum	 pharmacology	method,	Wei	 et al. treated 
human liver cancer cells cultured in vitro with low, medium, 
and	high	doses	of	XF	in	mouse	serum	and	5‑fluorouracil,	and	
used	clonogenesis	and	flow	cytometry	to	examine	the	effects	
on cell division, proliferation, and apoptosis.[87,88] The results 
showed that the XF drug serum had inhibitory and toxic 
effects	on	human	liver	cancer	cells.	In	addition	to	its	effects	




Monosaccharides are absorbed directly into the bloodstream 
through the small intestine, whereas disaccharides and 
Table 3: Sesquiterpenoids reported from Xanthii Fructus
Compound name Part of plant Reference
(2E,4E,1’S,2’R,4’S,6’R)‑dihydrophaseic	acid Fruits [24]
(3S,5R,6R,7E,9S)‑megastigman‑7ene‑3,5,6,9‑tetrol‑3‑O‑β‑D‑glucopyranoside Aerial parts [56]
(3S,5R,6S,7E)‑5,6‑epoxy‑3‑hydroxy‑7‑megastigmene‑9‑one Fruits [24]
11α,13‑dihydro‑8‑epi‑xanthatin Aerial parts [57]
11α,13‑dihydroxanthatin Aerial parts [58]
11α,13‑dihydroxanthuminol Leaves [59]
1β,4β,	4α,5α‑diepoxyxanth‑11(13)‑en‑12‑oic	acid Aerial parts [58]
1β,4β,4α,5α‑diepoxyxanth‑11 Fruits [58]
1β‑hydroxyl‑5α‑chloro‑8‑epi‑xanthatin Aerial parts [55]
2-hydroxy xanthinosin Aerial parts [60]
2-hydroxytomentosin Aerial parts [61]
2‑hydroxytomentosin‑1β,5β‑epoxide Aerial parts [58]
4-epi-isoxanthanol Aerial parts [58]
4-epi-xanthanol Aerial parts [58]
4-oxo-bedfordia acid Aerial parts [58]
4β,5β‑epoxyxanthatin‑1α,4α‑endoperoxide Aerial parts [58]
5-azuleneacetic acid Aerial parts [60]
6β,9β‑dihydroxy‑8‑epi‑xanthatin Fruits [63]
8-epi-tomentosin Leaves [57]
8-epi-xanthatin Aerial parts [62]
Desacetylxanthanol Leaves [65]
Dihydrophaseic	acid	sodium	salt	4’‑O‑β‑D‑glucopyranoside Fruits [56]
Inusoniolide Aerial parts [60]







Pungiolide A Aerial parts [64]
Pungiolide D Aerial parts [64]






Xanthnon Aerial parts [60]
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polysaccharides are converted into monosaccharides by 
alpha-glucose liver enzymes.[89] XF can reduce liver glycogen 
in animals, and a water extract of XF can inhibit the activity 
of alpha-glucose liver enzymes. The glycosides in XF can 
significantly reduce the blood glucose level induced by 
rhamnose, but cannot reduce the hyperglycemia caused by 
tetrafluorouracil	in	rats.	If	rhamnose	is	injected	first,	followed	
by epinephrine, the elevated blood sugar response of epinephrine 
decreases or is lost. Low, medium, and high doses of an XF 
decoction can reduce the blood glucose of normal mice, and 
are able to regulate blood glucose and maintain blood glucose 
stability. The medium- and high-dose XF decoctions can 
significantly	reduce	the	blood	glucose	of	hyperglycemia	mice	
and improve the glucose tolerance of hyperglycemia mice.[66,90,91]
Effects on immune function
Animal experiments have shown that XF has an inhibitory 
effect	on	both	humoral	and	cellular	immunity,	with	a	greater	
effect	 on	 cellular	 immunity.	 In	 addition,	XF	 displayed	 an	
inhibitory	 effect	 on	 the	 immune	 response	 of	mononuclear	
macrophages.[92] XF is not conducive to the increase in 
capillary	permeability	caused	by	histamine.	XF	significantly	
inhibits the expression of the interleukin-2 receptor, regulates 
the immune imbalance of Th cells in patients with asthma, 
and inhibits the release of inflammatory transmitters.[56] 
Experiments	have	shown	 that	XF	 induces	different	degrees	
of	weight	gain	in	immune	organs.	Specifically,	the	weight	of	
the thymus and spleen increased with an increasing dose, and 
the serum hemolysin value increased in mice.[93]
Effects on other physiological systems
In vitro animal experiments have shown that XF has an 
inhibitory	effect	on	the	heart,	and	can	slow	the	heart	rate	and	
reduce myocardial systolic function. Animal models have 
revealed	different	effects	of	XF	on	blood	vessels,	which	mainly	
functions to dilate blood vessels.[94] In addition, XF extracts 
exerted	an	obvious	antithrombin	effect.	Methanol	extract	had	
good	effect	on	the	recovery	of	cholesterol	triglyceride	level,	
Table 4: Lignanoids reported from Xanthii Fructus





1-(4-hydroxy-3-methoxy)-phenyl- 2-[4-(1,2,3-trihydroxypropyl)-2-methoxy]-phenoxy-1,3-propandiol Fruits [67]





Chushizisin E Fruits [67]
Dehydrodiconiferyl alcohol Fruits [67]
Dihydrodehydrodiconiferyl alcohol Fruits [67]
Diospyrosin Fruits [67]
Fructusol A Fruits [68]
Leptolepisol D Fruits [67]
Pinoresinol Fruits [24]
Syringaresinol Roots [31]
Threo-dihydroxydehydrodiconiferyl alcohol Fruits [67]
Xanthiumnolic	B Fruits [33]
Table 5: Thiazides reported from Xanthii Fructus






Aloe emodin Fruits [42]
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enhanced the phospholipid level, and inhibited the cholesterol 
and triglyceride level.[95] Moreover, the results of the study 
by Duan Xiaomao (2006) showed that compared with normal 
saline, chemical stimulation with XF and alcohol prolonged 
the	latent	period	of	cough	in	mice,	and	significantly	decreased	
the number of coughs. Compared with codeine, there was little 
difference	in	the	antitussive	effect.	This	indicates	that	XF	exerts	
an	antitussive	effect.
Figure 2: Chemical structure of phenylpropenoids reported from Xanthii Fructus
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Clinical application
XF is used to clinically treat rhinitis, sinusitis, urinary tract 
infection, upper respiratory infection, hypoglycemia, intractable 
toothache, malaria, chronic bronchitis, mumps, allergic diseases, 
urticaria, tumor, dermatitis, diarrhea, and otitis media.[90-98]
toxIcIty and sIde effects
The symptoms of XF poisoning are generally the same, 
regardless of the drug administration route. The activity of 
laboratory animals decreased upon XF administration.[95] 
Compared to normal animals, experimental animals were less 
active and responsive to external stimuli and had irregular 
breathing	and	extreme	breathing	difficulties	with	paroxysmal	
convulsion before they died.[96] The absolute lethal dose (LD100) 
of	a	25%	XF	emulsion	intraperitoneally	injected	into	rabbits	
was 10 mL/kg, and the median lethal dose (LD50) in mice 
was 7.5 mL/kg.[97] Histopathological examination of the main 
organs of various animals after poisoning revealed the same 
lesions,	differing	only	in	the	degree	of	severity.	Among	them,	
liver	injury	was	the	most	serious.[98] The livers of dead animals 
presented degenerative disease or even necrosis, and epithelial 
turbiditis in the curved tube of the kidney was similar to the 
symptoms of carbon tetrachloride poisoning.[99] Therefore, the 
main	consequence	of	XF	poisoning	 is	 liver	necrosis;	death	
may be due to convulsion caused by secondary brain edema. 
Many studies have found that the toxic components of XF 
may be related to toxic proteins or xanthium glycosides and 
alkaloids.[100] The toxicity of XF extract is proportional to the 
drug concentration.
The toxic components of XF were determined for medicinal 
xanthium herbs, decoction pieces, and representative 
formulations	containing	xanthium	(Biyuanshu	oral	liquid).	The	
results	showed	that	toxicity	was	observed	as	follows:	decoction	
pieces > medicinal material > prescription preparation. 
The results of acute toxicity tests showed that all the three 
preparations	in	mice	resulted	in	toxicity	as	follows:	decoction	
pieces > medicinal material > prescription preparation. The 
toxicity of decoction pieces was greater than that of medicinal 
herbs, which was consistent with the trend observed for 
atractylode content.[99]
Clinical adverse reactions of XF have been reported in clinical 
studies and mainly manifest in terms of damage to the skin, 
digestive system, nervous system, and cardiovascular system. 
The	 specific	 performance	was	 as	 follows:[94,96-101] first, skin 
lesions	manifest	as	a	systemic	rash	or	contact	dermatitis;	second,	
digestive system toxicity is characterized by nausea, vomiting, loss 
of appetite, abdominal distention, diarrhea, hematochezia, liver 
and kidney pain, liver enlargement, ascites, liver coma, abnormal 
liver	function,	and	liver	failure;	third,	nervous	system	symptoms	
include dizziness, headache, restlessness, convulsions, drowsiness, 
Figure 3: Chemical structure of glycosides reported from Xanthii Fructus
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Figure 4: Chemical structure of sesquiterpenoids reported from Xanthii Fructus
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confusion,	coma,	cerebral	edema,	and	aphasia;	fourth,	damage	to	
the cardiovascular system includes chest tightness, shortness of 
breath, decreased blood pressure, arrhythmia, and atrioventricular 
block;	fifth,	urinary	system	toxicity	is	characterized	by	edema,	
oliguria, urinary closure, hematuria, urinary incontinence, renal 
dysfunction,	and	acute	renal	failure;	sixth,	adverse	effects	of	XF	
on the respiratory system include dyspnea, irregular respiratory 
rhythms,	and	pulmonary	edema;	and	seventh,	damage	 to	 the	
hematopoietic system involves thrombocytopenic purpura, 
gingival bleeding, and cutaneous mucosal bleeding. Other side 
effects	include	neuroedema,	nosebleed,	lip	swelling,	hoarseness,	
and	difficulty	swallowing.
processIng and reducIng toxIcIty
XF is toxic to many organs, especially the liver and kidney.[66,101] 
Figure 5: Chemical structure of lignanoids reported from Xanthii Fructus
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Because	processing	can	reduce	the	toxicity	of	XF,	clinical	use	
generally involves processed products of XF.[23] In the Liu 
and	Song	dynasties	of	the	southern	and	northern	dynasties	of	
China, XF was steamed with Polygonatum sibiricum (Thunder 




Ming Dynasty of China, stir-fry and steaming were commonly 
used,	such	as	pastry	(Puji	formula),	micro	stir‑fry	(medicine),	
steaming with P. sibiricum	 juice	 (introduction),	 single	
steaming (Dafa), stir-fry to remove thorns, and wine mix steaming 
(Chengya). The Qing Dynasty of China used methods such as 
stir-frying and smashing (the law), and stir-frying, stir-frying 
with wine (Materia Medica). Presently, XF processing 
technology is generally divided into net and frying processes.[99] 
The cleaning process refers to the removal of cockle thorns and 
impurities. Common methods for the frying process include 
the clear frying method and the blanching method.[102] During 
this process, the blanching method is generally selected.[103-106] 
The optimal way to prepare XF to reduce its toxicity is to fry 
it and then grind the spines. For clinical use, it must be fried 
until brown to reduce toxicity.[107]
The chemical composition and pharmacological action of XF 
also change substantially before and after processing.
For phenolic acid, the content of total phenolic acid in XF was 
significantly	different	with	different	processing	temperatures	
and times, and the content ranged from 7.99 to 9.69 mg/g. 
The contents of new chlorogenic acid, chlorogenic acid, 
1,5‑dicaffeinic	acid,	and	total	phenolic	acid	in	the	decoction	
of XF after frying increased with increasing preparation 
temperature.[108,109]
For volatile and fatty oils, the content of fatty oil was 
significantly	 higher	 than	 that	 of	 crude	oil,	 but	 the	 physical	
constant	 changed	 little,	 and	 the	 specific	 gravity	 and	 acid	
values decreased slightly upon processing. Woody et al. (2013) 
qualitatively analyzed the changes in volatile oil and fat oil 
before	and	after	processing	of	XF	by	GC‑MS.	The	volatile	oil	in	
the raw products of XF included 18 chemical constituents, and 
the volatile oil in the fried products of XF included 13 chemical 
constituents.	Four	components	of	XF	were	identified	in	raw	and	
fried fat oil. The results showed that the chemical composition 
of	volatile	oil	was	different	before	and	after	processing,	while	
the composition of fat oil was not changed.[110]
For water-soluble glycosides and mixed protein, 
Han (2014)  found that the rate of XF seed protein extraction 
had	significantly	reduced	after	frying.[111] Duorui et al. (2013) 
found that the content of hydroxy atractylodes decreased to 
10%	after	XF	was	fried	to	yellow.	During	the	frying	process,	
hydroxy atractylodes were converted to atractylodes, and 
no carboxyl atractylodes were present after XF was fried to 
char. Moreover, atractylodes increased at temperatures of 
140°C–260°C	and	decreased	at	temperatures	above	260°C.
In 2008, Chen Daihong showed that processing could increase 
the	analgesic	effect	and	reduce	drug	toxicity.[43] In 2012, Wu 
Hui	compared	differences	in	the	toxicity	of	toxic	parts	before	
and after frying by means of an acute toxicity pharmacological 
test in mice, and showed that the fried products of xanthium 
have reduced toxicity.[56] Zhao et al. showed that a water 
decoction	and	fatty	oil	emulsion	of	XF	were	more	effective	
than the raw products against S. aureus and Pneumococcus.[112] 
In	2016,	the	anti‑inflammatory	effects	of	raw	XF	seed	products	
were	found	to	exceed	those	of	fried	products,	and	the	effects	
of processed drugs on blood glucose lowering were better than 
those of raw products.[43]	There	was	no	significant	difference	
between raw and fried xanthium in terms of blood glucose 
lowering.[113]
XF presents reduced toxicity after stir-frying. Therefore, XF 
should be used for medicinal purposes after stir-frying, but 
the temperature should be controlled strictly to prevent the 
loss	of	efficacy.
Figure 6: Chemical structure of thiazides reported from Xanthii Fructus
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future perspectIves and conclusIons
XF has been used for years in China as a drug to treat sinusitis. 
To date, national and international scientists have isolated 
100 chemical components from XF. The pharmacological 
activities of its chemical components have mainly focused 
on phenylpropanoids and sesquiterpenoids, while studies on 
lignanoids and thiazides are relatively rare. In addition, the 
decreased toxicity of XF before and after processing may 
be	related	to	changes	in	the	chemical	composition;	however,	
experimental evidence to support this is lacking. In this article, 
the chemical components of XF are summarized, which is 
expected to be helpful for the research and development of 
new drugs, especially in terms of its pharmacodynamics and 
structure–activity	relationship.
In terms of pharmacology, XF is often used in the clinical 
treatment of allergic diseases, suggesting that it may have 
immunosuppressive	and	anti‑allergy	effects;	however,	there	
has been no reasonable explanation to explain its clinical 
efficacy.	 Network	 pharmacology	 is	 commonly	 used	 to	
analyze the mechanism of action of XF, and may represent 
a suitable method for studies on its mechanism of action. At 
the same time, researchers should perform further in vitro 
and in vivo experiments to elucidate the full therapeutic 
potential of XF.
With the development of natural medicinal chemistry, more 
attention must be paid to TCM. XF contains abundant 
medicinal plant resources and is widely distributed 
in China. In this article, the chemical components, 
analytical methods, pharmacological effects, clinical 
application, toxicity, and processing technology of XF are 
systematically reviewed, and some issues that need to be 
overcome are discussed, in order to provide a direction for 
the future study of XF.
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